STOCK TITAN

Publication relating to transparency notifications

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Nyxoah SA announced receiving a transparency notification from ResMed Inc. regarding a passive threshold crossing. According to the notification dated November 5, 2024, ResMed Inc. now holds 1,727,864 voting rights, representing 4.62% of the total voting rights (37,389,015) as of October 9, 2024. This represents a decrease below the 5% threshold. ResMed Inc. is not a controlled entity and holds these voting rights directly without any indirect holdings.

Nyxoah SA ha annunciato di aver ricevuto una comunicazione di trasparenza da ResMed Inc. riguardo a un superamento della soglia passiva. Secondo la comunicazione datata 5 novembre 2024, ResMed Inc. ora detiene 1.727.864 diritti di voto, che rappresentano il 4,62% del totale dei diritti di voto (37.389.015) al 9 ottobre 2024. Questo rappresenta una diminuzione sotto la soglia del 5%. ResMed Inc. non è un'entità controllata e detiene questi diritti di voto direttamente senza alcuna partecipazione indiretta.

Nyxoah SA anunció haber recibido una notificación de transparencia de ResMed Inc. respecto a un cruce de umbral pasivo. Según la notificación fechada el 5 de noviembre de 2024, ResMed Inc. ahora posee 1.727.864 derechos de voto, que representan el 4,62% del total de derechos de voto (37.389.015) a partir del 9 de octubre de 2024. Esto representa una disminución por debajo del umbral del 5%. ResMed Inc. no es una entidad controlada y posee estos derechos de voto directamente sin participaciones indirectas.

Nyxoah SA는 ResMed Inc.로부터 수동 역치 초과에 대한 투명성 통지를 받았다고 발표했습니다. 2024년 11월 5일자 통지에 따르면, ResMed Inc.는 현재 1,727,864개의 의결권을 보유하고 있으며, 이는 2024년 10월 9일 기준 전체 의결권(37,389,015)의 4.62%에 해당합니다. 이는 5% 역치를 아래로 감소한 것입니다. ResMed Inc.는 제어된 개체가 아니며 간접 소유 없이 이 의결권을 직접 보유하고 있습니다.

Nyxoah SA a annoncé avoir reçu une notification de transparence de ResMed Inc. concernant un franchissement de seuil passif. Selon la notification datée du 5 novembre 2024, ResMed Inc. détient désormais 1.727.864 droits de vote, ce qui représente 4,62% du total des droits de vote (37.389.015) au 9 octobre 2024. Cela représente une diminution en dessous du seuil de 5%. ResMed Inc. n'est pas une entité contrôlée et détient ces droits de vote directement sans détention indirecte.

Nyxoah SA hat bekannt gegeben, eine Transparenzmitteilung von ResMed Inc. bezüglich eines passiven Schwellenwertüberschreitens erhalten zu haben. Laut der Mitteilung vom 5. November 2024 hält ResMed Inc. nun 1.727.864 Stimmrechte, was 4,62% der gesamten Stimmrechte (37.389.015) zum 9. Oktober 2024 entspricht. Dies stellt einen Rückgang unter die 5%-Schwelle dar. ResMed Inc. ist kein kontrolliertes Unternehmen und hält diese Stimmrechte direkt ohne indirekte Beteiligungen.

Positive
  • None.
Negative
  • None.

Insights

The transparency notification from ResMed Inc. reveals a decrease in voting rights percentage to 4.62%, falling below the 5% threshold. This passive crossing occurred due to dilution from share issuance rather than active selling. While ResMed holds 1,727,864 voting rights, up from their previous 1,619,756 shares, the increased total share count of 37,389,015 reduced their overall percentage ownership.

This development has minimal immediate market impact but indicates continued institutional interest in Nyxoah's growth story. The passive nature of the threshold crossing suggests no strategic shift in ResMed's investment stance. For retail investors, this regulatory disclosure maintains transparency but doesn't signal any fundamental changes in company outlook or institutional confidence.

                

REGULATED INFORMATION

Publication relating to transparency notifications

Mont-Saint-Guibert (Belgium), November 18, 2024, 10:30 pm CET / 4:30 pm ET In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below.

On November 15, 2024, Nyxoah received a transparency notification from ResMed Inc. following the passive crossing of a threshold. Based on the notification, ResMed Inc. holds 1,727,864 voting rights, representing 4.62% of the total number of voting rights on October 9, 2024 (37,389,015).

The notification dated November 5, 2024 contains the following information:

  • Reason for the notification: passive crossing of a threshold
  • Notification by: a person that notifies alone
  • Persons subject to the notification requirement:
    • ResMed Inc. (with address at 9001 Spectrum Center Boulevard, San Diego, CA 92123, USA)
  • Date on which the threshold was crossed: October 9, 2024
  • Threshold that is crossed: 5%
  • Denominator: 37,389,015
  • Notified details:
A) Voting rights Previous notification After the transaction

 
# of voting rights # of voting rights % of voting rights
Holders of voting rights
 
Linked to securities Not linked to the securities Linked to securities Not linked to the securities
ResMed Inc. 1,619,756 1,727,864
 

 

 

 
TOTAL 1,727,864 0 4.62% 0.00%
  • Full chain of controlled undertakings through which the holding is effectively held: No indirect holding of voting securities. ResMed Inc. is not a controlled entity.

*

* *

Contact:
Nyxoah
John Landry, CFO
IR@nyxoah.com

Attachment


FAQ

What percentage of Nyxoah (NYXH) voting rights does ResMed Inc. currently hold?

According to the transparency notification, ResMed Inc. holds 4.62% of Nyxoah's voting rights as of October 9, 2024.

How many voting rights does ResMed Inc. hold in Nyxoah (NYXH)?

ResMed Inc. holds 1,727,864 voting rights in Nyxoah.

What threshold did ResMed Inc. cross in its Nyxoah (NYXH) shareholding?

ResMed Inc. passively crossed below the 5% threshold in its Nyxoah shareholding.

When did ResMed Inc. cross the threshold in Nyxoah (NYXH)?

ResMed Inc. crossed the threshold on October 9, 2024.

Nyxoah SA Ordinary Shares

NASDAQ:NYXH

NYXH Rankings

NYXH Latest News

NYXH Stock Data

292.18M
22.46M
41.74%
35.37%
0.12%
Medical Instruments & Supplies
Healthcare
Link
United States of America
Mont-Saint-Guibert